Get started
Alkermes plcAlkermes plcAlkermes plc

Alkermes plc

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ALKS chart

Key stats

Market capitalization
‪4.01 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
11.80
Basic EPS (TTM)
2.13USD
Net income
‪355.76 M‬USD
Revenue
‪1.66 B‬USD
Shares float
‪164.62 M‬
Beta (1Y)
0.54

About Alkermes plc

Sector
Health Technology
CEO
Richard F. Pops
Headquarters
Dublin
Website
alkermes.com
Employees (FY)
‪2.1 K‬
Founded
2011
ISIN
IE00B56GVS15
FIGI
BBG000C9F2F9
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALKS is 24.08 USD — it has increased by 0.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alkermes plc stocks are traded under the ticker ALKS.
Alkermes plc is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Alkermes plc has a max estimate of 50.00 USD and a min estimate of 23.00 USD.
ALKS earnings for the last quarter are 0.59 USD whereas the estimation was 0.40 USD which accounts for 50.23% surprise. Estimated earnings for the next quarter are 0.45 USD. See more details about Alkermes plc earnings.
Alkermes plc revenue for the last quarter amounts to ‪380.94 M‬ USD despite the estimated figure of ‪362.31 M‬ USD. In the next quarter revenue is expected to reach ‪362.22 M‬ USD.
Yes, you can track Alkermes plc financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALKS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alkermes plc stock right from TradingView charts — choose your broker and connect to your account.
ALKS reached its all-time high on Mar 1, 2000 with the price of 98.50 USD, and its all-time low was 0.94 USD and was reached on Dec 19, 1994.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is Alkermes plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alkermes plc EBITDA is ‪364.79 M‬ USD, and current EBITDA margin is 29.40%. See more stats in Alkermes plc financial statements.